Is Agile Therapeutics Inc (AGRX) a Stock to Watch After Gaining 37.22% This Week?

Agile Therapeutics Inc (AGRX) stock has gained 37.22% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Agile Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on AGRX!

See Full AGRX Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With AGRX Stock Today?

Agile Therapeutics Inc (AGRX) stock is higher by 2.92% while the S&P 500 is lower by -0.09% as of 10:36 AM on Monday, Oct 2. AGRX has gained $0.07 from the previous closing price of $2.40 on volume of 37,739 shares. Over the past year the S&P 500 has gained 16.47% while AGRX is lower by -83.80%. AGRX earned $5.93 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 0.42.

More About Agile Therapeutics Inc

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. Click Here to get the full Stock Report for Agile Therapeutics Inc stock.